ARDT · Ardent Health, Inc.
$10.91
-0.11 (-1.00%)
At close · Aug 14
Market Cap
$1.54B
Shares
141.05M
Ardent Health, Inc. Earnings Call Transcripts
Every quarterly earnings call for Ardent Health, Inc. (ARDT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲7.5%
$1.47B
$42.77M
'24 Q2
24-08-15
▲5.2%
$1.45B
$26.32M
'24 Q3
24-11-07
·
$1.61B
$114.20M
'24 Q4
25-02-27
▲4%
$1.50B
$41.38M
'25 Q1
25-05-07
▲11.9%
$1.65B
$72.95M
'25 Q2
25-08-06
▲8.8%
$1.58B
−$23.48M
'25 Q3
25-11-13
▼0.1%
$1.61B
$44.96M
'25 Q4
26-03-05
▲7%
$1.60B
$39.85M
'26 Q1
26-05-06
LATEST
▼1.4%
$1.62B
$16.90M
'26 Q2
26-08-05
Earnings call
FY26 · Q2
2026-08-05
Ardent Health Second Quarter 2026 Earnings Conference Call
Confident tone
Service line optimization and portfolio rationalization
IMPACT cost savings program
Access points expansion (urgent care / ASC)
Revenue
$1.62B
▼ 1.4% YoY Diluted EPS
$0.12
▼ 76.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-10
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-06
Ardent Health, Inc. Q1 FY2026 Earnings Call
Confident tone
IMPACT cost savings program
Industry headwinds (weather, flu, payer denials)
Labor and supply cost discipline
Revenue
$1.60B
▲ 7% YoY Diluted EPS
$0.28
▼ 3.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-05
Ardent Health, Inc. Q4 FY2025 Earnings Call
Positive tone
2025 Financial Results
Market Growth and Demand
IMPACT Program / Margin Transformation
Revenue
$1.61B*
▼ 0.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Ardent Health, Inc. Q3 FY2025 Earnings Call
Positive tone
Adjusted EBITDA guidance revision
IMPACT cost initiative
Industry headwinds on costs
Revenue
$1.58B
▲ 8.8% YoY Diluted EPS
$-0.17
▼ 189.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Ardent Health, Inc. Q2 FY2025 Earnings Call
Positive tone
Strategic growth and outpatient expansion
Demand and quarterly financial performance
IMPACT margin expansion program
Revenue
$1.65B
▲ 11.9% YoY Diluted EPS
$0.52
▲ 52.9% YoY
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Ardent Health, Inc. Q1 FY2025 Earnings Call
Positive tone
Volume growth and demand
Oncology/infusion service transfer
Margin expansion and cost initiatives
Revenue
$1.50B
▲ 4% YoY Diluted EPS
$0.29
▲ 38.1% YoY
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Ardent Health, Inc. Q4 FY2024 Earnings Call
Confident tone
2024 financial performance
New Mexico DPP
2025 guidance and outlook
Revenue
$1.61B*
Rev · 5q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Ardent Health, Inc. Q3 FY2024 Earnings Call
Confident tone
Margin Expansion and Adjusted EBITDA
Volume Growth and Demand
Ambulatory and Outpatient Growth Strategy
Revenue
$1.45B
▲ 5.2% YoY Diluted EPS
$0.19
▲ 11.8% YoY
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-15
Ardent Health, Inc. Q2 FY2024 Earnings Call
Confident tone
Revenue and Adjusted EBITDA growth
2024 guidance
Service line optimization
Revenue
$1.47B
▲ 7.5% YoY Diluted EPS
$0.34
▲ 30.8% YoY
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Showing 1–10 of 10 earnings calls
Key facts
CIK
1756655
CUSIP
03980N107
13F (30d)
135 filings
132 filers
Visit website
Investor relations